Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today
Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today

We deliver Mobile Wallet Market Research and SWOT Analysis from Alternative Energy to Pharmaceuticals and Healthcare Market Research Reports to Digital Media.

Skip to Main Content »

Search Site
Researchers Currently Online:2151

Hepatitis B Global Clinical Trials Review, Q2, 2011

Hepatitis B Global Clinical Trials Review, Q2, 2011

Double click on above image to view full picture

Zoom Out
Zoom In
Additional Information
Price $1,000.00
Meta Description Hepatitis B Global Clinical Trials Review, Q2, 2011

Summary

GlobalData's clinical trial report, “Hepatitis B Global Clinical
Publisher GlobalData
Date of Report Jun 15, 2011
Quick Overview
Hepatitis B Global Clinical Trials Review, Q2, 2011

Summary

GlobalData's clinical trial report, “Hepatitis B Global Clinical Trials Review, Q2, 2011" provides data on the Hepatitis B clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatitis B. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatitis B. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Hepatitis B 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Unaccomplished Trials of Hepatitis B 21
Subjects Recruited Over a Period of Time 25
Prominent Sponsors 26
Top Companies Participating in Hepatitis B Therapeutics Clinical Trials 28
Prominent Drug Comparison 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
GlaxoSmithKline plc 31
Clinical Trial Overview of GlaxoSmithKline plc 31
Bristol-Myers Squibb Company 37
Clinical Trial Overview of Bristol-Myers Squibb Company 37
Gilead Sciences, Inc. 39
Clinical Trial Overview of Gilead Sciences, Inc. 39
Novartis AG 41
Clinical Trial Overview of Novartis AG 41
Bukwang Pharmaceutical Co., Ltd. 42
Clinical Trial Overview of Bukwang Pharmaceutical Co., Ltd. 42
Sanofi 43
Clinical Trial Overview of Sanofi 43
F. Hoffmann-La Roche Ltd. 45
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 45
Merck & Co., Inc. 46
Clinical Trial Overview of Merck & Co., Inc. 46
Dynavax Technologies Corporation 47
Clinical Trial Overview of Dynavax Technologies Corporation 47
Idenix Pharmaceuticals, Inc. 48
Clinical Trial Overview of Idenix Pharmaceuticals, Inc. 48
LG Life Sciences, Ltd 49
Clinical Trial Overview of LG Life Sciences, Ltd 49
Groupe Novasep 50
Clinical Trial Overview of Groupe Novasep 50
Achillion Pharmaceuticals, Inc. 51
Clinical Trial Overview of Achillion Pharmaceuticals, Inc. 51
Biological E. Limited 52
Clinical Trial Overview of Biological E. Limited 52
Cangene Corporation 53
Clinical Trial Overview of Cangene Corporation 53
Pharmasset, Inc 54
Clinical Trial Overview of Pharmasset, Inc 54
Shantha Biotechnics Limited 55
Clinical Trial Overview of Shantha Biotechnics Limited 55
Crucell Holland B.V 56
Clinical Trial Overview of Crucell Holland B.V 56
Valeant Pharmaceuticals North America Inc. 57
Clinical Trial Overview of Valeant Pharmaceuticals North America Inc. 57
Clinical Trial Overview of Top Universities / Institutes / Hospitals 58
The National Institute of Allergy and Infectious Diseases 58
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 58
The National Institute of Diabetes and Digestive and Kidney Diseases 59
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 59
French National Agency for Research on AIDS and Viral Hepatitis 60
Clinical Trial Overview of French National Agency for Research on AIDS and Viral Hepatitis 60
Okayama University 61
Clinical Trial Overview of Okayama University 61
Sun Yat-sen University 62
Clinical Trial Overview of Sun Yat-sen University 62
Chinese University of Hong Kong 63
Clinical Trial Overview of Chinese University of Hong Kong 63
University Health Network 64
Clinical Trial Overview of University Health Network 64
University of Pittsburgh 65
Clinical Trial Overview of University of Pittsburgh 65
Yonsei University 66
Clinical Trial Overview of Yonsei University 66
Serum Institute of India Limited 67
Clinical Trial Overview of Serum Institute of India Limited 67
The HIV Netherlands Australia Thailand Research Collaboration 68
Clinical Trial Overview of The HIV Netherlands Australia Thailand Research Collaboration 68
Stanford University 69
Clinical Trial Overview of Stanford University 69
Centers for Disease Control and Prevention 70
Clinical Trial Overview of Centers for Disease Control and Prevention 70
Kyoto University 71
Clinical Trial Overview of Kyoto University 71
The University of Hong Kong 72
Clinical Trial Overview of The University of Hong Kong 72
University of California, Los Angeles 73
Clinical Trial Overview of University of California, Los Angeles 73
The University of Tokyo 74
Clinical Trial Overview of The University of Tokyo 74
Seoul National University Hospital 75
Clinical Trial Overview of Seoul National University Hospital 75
Hospital Authority 76
Clinical Trial Overview of Hospital Authority 76
Hyogo College Of Medicine 77
Clinical Trial Overview of Hyogo College Of Medicine 77
Appendix 78
Abbreviations 78
Definitions 78
Research Methodology 79
Secondary Research 79
About GlobalData 80
Contact Us 80
Disclaimer 80
Source 80




...